Close
FINDING CURES TOGETHER<sup>SM</sup>

Science Policy and Government Affairs Committee    

The Science Policy and Government Affairs Committee is AACR's principal means for devising and implementing strategies to influence important biomedical research-related public policy issues. The committee analyzes public issues of concern to cancer researchers and focuses on mechanisms for speeding up cancer research. Its members periodically visit legislators in Washington, D.C. to make the case for increased funding for all forms of biomedical research, periodically submit testimony to Congress, government agencies and advisory boards and help shape special sessions to educate members of Congress and their staff about important issues affecting cancer research.

            Function                       Composition

            Members                      Science Policy Subcommittees

Function    

For more than 25 years, the Science Policy and Government Affairs Committee (and its precursor, the Public Education Committee) has served as AACR's principal means for devising and implementing strategies to influence important biomedical research-related public policy issues. The committee analyzes public issues of concern to cancer researchers, focuses on mechanisms for strengthening funding for cancer research, and recommends appropriate activities to the AACR Board of Directors. The members of the committee periodically visit legislators in Washington, D.C., to make the case for increased funding for all forms of biomedical research. In the fall of 2007, the AACR opened a Washington, D.C. office to further strengthen its ability to represent the interests of cancer researchers before Congress.

Composition      

The president of the AACR appoints members to the Science Policy and Government Affairs Committee based upon their interest and expertise. Members serve on the committee for a three-year renewable term. The committee ordinarily meets once or twice a year, often in Washington, D.C.  It is staffed by the AACR Office of Science Policy and Government Affairs in Washington, D.C.

2014-2015 Members     

William S. Dalton, MD, PhD (Chairperson)
Roy S. Herbst, MD, PhD (Vice Chairperson)
George J. Weiner, MD (Vice Chairperson)
Francis Ali-Osman, DSc
Kenneth C. Anderson, MD
Anna D. Barker, PhD
Mary C. Beckerle, PhD
A. William Blackstock, MD
Michael A. Caligiuri, MD
Renzo Canetta, MD
Robert S. DiPaola, MD
Raymond N. DuBois, Jr., MD, PhD, FAACR
H. Shelton Earp, III, MD
Judy E. Garber, MD, MPH, FAACR
Stephan A. Grupp, MD, PhD
Ernest T. Hawk, PhD, MPH
Roy A. Jensen, MD
Karen E. Knudsen, PhD
Richard E. Kouri, PhD
Michelle Le Beau, PhD
Frank McCormick, PhD, FAACR
William G. Nelson, MD, PhD
Gilbert S. Omenn, MD, PhD
Steven R. Patierno, PhD
Edith A. Perez, MD
David M. Reese, MD
Victoria M. Richon, PhD
Steven T. Rosen, MD
Eric H. Rubin, MD
Ellen V. Sigal, PhD
Steven H. Stein, MD
Dan Theodorescu, MD, PhD
Laura J. van ’t Veer, PhD
Louis M. Weiner, MD
Cheryl L. Willman, MD
Douglas Yee, MD
Robert C. Young, MD
Carlos L. Arteaga, MD (ex officio)
José Baselga, MD, PhD, FAACR (ex officio)
Charles L. Sawyers, MD, FAACR (ex officio)
Anna Woloszynska-Read, PhD (ex officio)

Science Policy Subcommittees    

The Science Policy and Government Affairs Committee oversees three subcommittees engaged in specific science policy matters.

  • AACR Regulatory Science and Policy Subcommittee. The Regulatory Science and Policy Subcommittee was established in March 2011 with the goal of supporting the efforts of FDA to modernize the regulatory process and accommodate the fast pace of innovation in science and technology.
  • AACR Tobacco and Cancer Subcommittee. The Tobacco and Cancer Subcommittee was established in 2009 to foster scientific and policy initiatives to reduce the incidence of disease and mortality due to tobacco use.
  • AACR Health Policy Subcommittee. The Health Policy Subcommittee was established in 2011 to develop and promote policies and member education initiatives that will foster the closer integration of clinical practice and cancer research.

Top

Dr. Michelle M. LeBeau